BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 19878544)

  • 1. Fibrocytes are associated with vascular and parenchymal remodelling in patients with obliterative bronchiolitis.
    Andersson-Sjöland A; Erjefält JS; Bjermer L; Eriksson L; Westergren-Thorsson G
    Respir Res; 2009 Oct; 10(1):103. PubMed ID: 19878544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrocytes are a potential source of lung fibroblasts in idiopathic pulmonary fibrosis.
    Andersson-Sjöland A; de Alba CG; Nihlberg K; Becerril C; Ramírez R; Pardo A; Westergren-Thorsson G; Selman M
    Int J Biochem Cell Biol; 2008; 40(10):2129-40. PubMed ID: 18374622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating fibrocytes correlate with bronchiolitis obliterans syndrome development after lung transplantation: a novel clinical biomarker.
    LaPar DJ; Burdick MD; Emaminia A; Harris DA; Strieter BA; Liu L; Robbins M; Kron IL; Strieter RM; Lau CL
    Ann Thorac Surg; 2011 Aug; 92(2):470-7; discussion 477. PubMed ID: 21801908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obliterative airway remodelling in transplanted and non-transplanted lungs.
    Jonigk D; Theophile K; Hussein K; Bock O; Lehmann U; Bockmeyer CL; Gottlieb J; Fischer S; Simon A; Welte T; Maegel L; Kreipe H; Laenger F
    Virchows Arch; 2010 Sep; 457(3):369-80. PubMed ID: 20632031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transforming growth factor beta (TGF-beta) and obliterative bronchiolitis following pulmonary transplantation.
    El-Gamel A; Sim E; Hasleton P; Hutchinson J; Yonan N; Egan J; Campbell C; Rahman A; Sheldon S; Deiraniya A; Hutchinson IV
    J Heart Lung Transplant; 1999 Sep; 18(9):828-37. PubMed ID: 10528744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. VEGF synthesis and VEGF receptor 2 expression in patients with bronchiolitis obliterans syndrome after lung transplantation.
    Larsson-Callerfelt AK; Müller C; Andersson-Sjöland A; Thiman L; Larsson H; Hallgren O; Bjermer L; Eriksson L; Westergren-Thorsson G
    Respir Med; 2020 May; 166():105944. PubMed ID: 32250877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does bronchial artery revascularization influence results concerning bronchiolitis obliterans syndrome and/or obliterative bronchiolitis after lung transplantation?
    Nørgaard MA; Andersen CB; Pettersson G
    Eur J Cardiothorac Surg; 1998 Sep; 14(3):311-8. PubMed ID: 9761443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is obliterative bronchiolitis in lung transplantation associated with microvascular damage to small airways?
    Luckraz H; Goddard M; McNeil K; Atkinson C; Sharples LD; Wallwork J
    Ann Thorac Surg; 2006 Oct; 82(4):1212-8. PubMed ID: 16996910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microvascular changes in small airways predispose to obliterative bronchiolitis after lung transplantation.
    Luckraz H; Goddard M; McNeil K; Atkinson C; Charman SC; Stewart S; Wallwork J
    J Heart Lung Transplant; 2004 May; 23(5):527-31. PubMed ID: 15135366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of obliterative bronchiolitis (OB) by prolyl-hydroxylase-inhibitors activating hypoxia-inducible transcription factors in an experimental mouse model.
    Heim C; Motsch B; Jalilova S; Bernhardt WM; Ramsperger-Gleixner M; Burzlaff N; Weyand M; Eckardt KU; Ensminger SM
    Transpl Immunol; 2016 Nov; 39():66-73. PubMed ID: 27590486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restrictive allograft syndrome post lung transplantation is characterized by pleuroparenchymal fibroelastosis.
    Ofek E; Sato M; Saito T; Wagnetz U; Roberts HC; Chaparro C; Waddell TK; Singer LG; Hutcheon MA; Keshavjee S; Hwang DM
    Mod Pathol; 2013 Mar; 26(3):350-6. PubMed ID: 23018877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obliterative bronchiolitis after lung transplantation: a fibroproliferative disorder associated with platelet-derived growth factor.
    Hertz MI; Henke CA; Nakhleh RE; Harmon KR; Marinelli WA; Fox JM; Kubo SH; Shumway SJ; Bolman RM; Bitterman PB
    Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10385-9. PubMed ID: 1438225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of intrapulmonary de novo lymphoid tissue in obliterative bronchiolitis after lung transplantation.
    Sato M; Hirayama S; Hwang DM; Lara-Guerra H; Wagnetz D; Waddell TK; Liu M; Keshavjee S
    J Immunol; 2009 Jun; 182(11):7307-16. PubMed ID: 19454728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibroblasts of recipient origin contribute to bronchiolitis obliterans in human lung transplants.
    Bröcker V; Länger F; Fellous TG; Mengel M; Brittan M; Bredt M; Milde S; Welte T; Eder M; Haverich A; Alison MR; Kreipe H; Lehmann U
    Am J Respir Crit Care Med; 2006 Jun; 173(11):1276-82. PubMed ID: 16528017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel charcoal-induced model of obliterative bronchiolitis-like lesions: implications of chronic nonspecific airway inflammation in the development of posttransplantation obliterative bronchiolitis.
    Lee AG; Wagner FM; Chen MF; Serrick C; Giaid A; Shennib H
    J Thorac Cardiovasc Surg; 1998 Apr; 115(4):822-7. PubMed ID: 9576217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Airway vascular changes after lung transplant: potential contribution to the pathophysiology of bronchiolitis obliterans syndrome.
    Langenbach SY; Zheng L; McWilliams T; Levvey B; Orsida B; Bailey M; Williams TJ; Snell GI
    J Heart Lung Transplant; 2005 Oct; 24(10):1550-6. PubMed ID: 16210129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for the development of bronchiolitis obliterans syndrome after lung transplantation.
    Kroshus TJ; Kshettry VR; Savik K; John R; Hertz MI; Bolman RM
    J Thorac Cardiovasc Surg; 1997 Aug; 114(2):195-202. PubMed ID: 9270635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obliterative bronchiolitis in lung allografts removed at retransplant for intractable airway problems.
    Akindipe O; Fernandez-Bussy S; Jantz M; Lu L; Deem A; Swafford W; Staples E; Baz M
    Respirology; 2009 May; 14(4):601-5. PubMed ID: 19383111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone marrow-derived progenitor cells in end-stage lung disease patients.
    Gilpin SE; Lung K; de Couto GT; Cypel M; Sato M; Singer LG; Keshavjee S; Waddell TK
    BMC Pulm Med; 2013 Aug; 13():48. PubMed ID: 23915095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eosinophilic granulocytes and interleukin-6 level in bronchoalveolar lavage fluid are associated with the development of obliterative bronchiolitis after lung transplantation.
    Scholma J; Slebos DJ; Boezen HM; van den Berg JW; van der Bij W; de Boer WJ; Koëter GH; Timens W; Kauffman HF; Postma DS
    Am J Respir Crit Care Med; 2000 Dec; 162(6):2221-5. PubMed ID: 11112142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.